$GILD Is Building a Base for a Recovery Toward $140+

$Gilead Sciences(GILD)$

$Gilead Sciences, Inc.(GILD) Rebounds +2.96%: Biotech Giant Finds Support, Eyes Resistance Break 🧬

Latest Close Data

Closed at $134.36 (+$3.86, +2.96%) on 2026-05-25, still ~14.6% below its 52-week high of $157.29.

Core Market Drivers

  1. The rebound follows a sharp sell-off triggered by the company's May 8 announcement of a significant downward revision to its full-year profit guidance due to a massive acquisition cost.

  2. However, Q1 earnings released earlier in May exceeded expectations, with revenue up 4% and EPS of $2.03 beating estimates, providing underlying support.

Technical Analysis

  • Today's volume of 5.97M shares shows average participation (Volume Ratio: 1.09).

  • The RSI(6) surged to 66.24, indicating strong short-term momentum and exiting oversold territory.

  • The MACD histogram turned positive to 0.62, suggesting bullish momentum is building, though the DIF and DEA lines remain negative, indicating the trend reversal is in its early stages.

Key Price Levels

  • Primary Support: $121.28 (Recent swing low, crucial for the bullish structure).

  • Strong Resistance: $139.68 (Immediate ceiling, a break above could signal trend continuation).

  • Immediate Pivot: ~$134.36 (Today's close, acts as the new base for the next move).

Valuation Perspective

The stock trades at a P/E (TTM) of 18.27, which is reasonable for a large-cap biopharma. However, the Forward P/E appears negative due to the significant one-time acquisition charge, making historical comparisons less meaningful in the near term.

Analyst Targets

Analysts remain cautiously optimistic. Among 33 analysts surveyed, 9 rate it Strong Buy, 18 Buy, and 6 Hold. The average 12-month price target is $158.29, implying ~18% upside from the current level.

Weekly Outlook

Expect consolidation between $130-$140 in the coming week as the market digests the guidance reset. A sustained break above $139.68 could target the $145-$150 zone. Conversely, a fall below $121.28 could see a retest of the $115 support area.

Risk Disclaimer This analysis is for informational purposes only and not investment advice. Past performance is not indicative of future results. Investing involves risk, including potential loss of principal. Conduct your own research or consult a financial advisor before making any investment decisions.


😍 Been eyeing Tiger merch but short on Tiger Coins? Now's your chance.

🎁 We’ve selected 4 high-demand items across practial, lifestyle, and learning, now with a lower redemption threshold!

Hot Merch Returns · Up to 43% Off

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet